It has initially been suggested that in particular antibodies against myelin oligodendrocyte glycoprotein (MOG) and myelin basic protein (MBP) were predictive of a conversion from a clinically-isolated syndrome (CIS) to clinically definite MS [27]. Here, OMG is linked to in situ carcinoma.